| RS2517153214 |
ITGB2
|
Health Risk |
Pathogenic |
Leukocyte adhesion deficiency 1, Leukocyte adhesion deficiency 1 |
| RS2517154868 |
RTEL1
|
Health Risk |
Likely pathogenic |
Dyskeratosis congenita, autosomal recessive 5 |
| RS2517154875 |
RTEL1
|
Health Risk |
Likely pathogenic |
Dyskeratosis congenita, autosomal recessive 5 |
| RS2517155046 |
RTEL1
|
Health Risk |
Pathogenic |
Dyskeratosis congenita, autosomal recessive 5 |
| RS2517158918 |
IL17RA
|
Health Risk |
Pathogenic |
Immunodeficiency 51, Immunodeficiency 51 |
| RS2517159112 |
IL17RA
|
Health Risk |
Likely pathogenic |
Immunodeficiency 51, Immunodeficiency 51 |
| RS2517164324 |
IL17RA
|
Health Risk |
Likely pathogenic |
Chronic mucocutaneous candidiasis, Chronic mucocutaneous candidiasis |
| RS2517164422 |
RTEL1
|
Health Risk |
Likely pathogenic |
Dyskeratosis congenita, autosomal recessive 5 |
| RS2517164471 |
RTEL1
|
Health Risk |
Likely pathogenic |
Dyskeratosis congenita, autosomal recessive 5 |
| RS2517164580 |
IL17RA
|
Health Risk |
Pathogenic |
Immunodeficiency 51, Immunodeficiency 51 |
| RS2517164767 |
RTEL1
|
Health Risk |
Likely pathogenic |
Dyskeratosis congenita, autosomal recessive 5 |
| RS2517165249 |
RTEL1
|
Health Risk |
Likely pathogenic |
Dyskeratosis congenita, autosomal recessive 5 |
| RS2517165274 |
ITGB2
|
Health Risk |
Pathogenic/Likely pathogenic |
ITGB2-related disorder, Leukocyte adhesion deficiency 1 |
| RS2517165410 |
RTEL1
|
Health Risk |
Pathogenic |
Pulmonary fibrosis and/or bone marrow failure, Telomere-related |
| RS2517165422 |
RTEL1
|
Health Risk |
Pathogenic |
Dyskeratosis congenita, autosomal recessive 5 |
| RS2517165576 |
ITGB2
|
Health Risk |
Likely pathogenic |
Leukocyte adhesion deficiency 1, Leukocyte adhesion deficiency 1 |
| RS2517166028 |
IL17RA
|
Health Risk |
Likely pathogenic |
Immunodeficiency 51, Immunodeficiency 51 |
| RS2517166188 |
RTEL1
|
Health Risk |
Likely pathogenic |
Dyskeratosis congenita, autosomal recessive 5 |
| RS2517166359 |
RTEL1
|
Health Risk |
Likely pathogenic |
Dyskeratosis congenita, autosomal recessive 5 |
| RS2517166376 |
RTEL1
|
Health Risk |
Pathogenic |
Pulmonary fibrosis and/or bone marrow failure, Telomere-related |
| RS2517168002 |
CNOT3
|
Health Risk |
Pathogenic |
Inborn genetic diseases, Inborn genetic diseases |
| RS2517169913 |
RTEL1
|
Health Risk |
Pathogenic |
Pulmonary fibrosis and/or bone marrow failure, Telomere-related |
| RS2517170083 |
RTEL1
|
Health Risk |
Pathogenic/Likely pathogenic |
Pulmonary fibrosis and/or bone marrow failure, Telomere-related |
| RS2517170616 |
RTEL1
|
Health Risk |
Pathogenic |
Dyskeratosis congenita, autosomal recessive 5 |
| RS2517170691 |
RTEL1
|
Health Risk |
Likely pathogenic |
Dyskeratosis congenita, autosomal recessive 5 |
| RS2517171405 |
CSTB
|
Health Risk |
Pathogenic |
Progressive myoclonic epilepsy, Progressive myoclonic epilepsy |
| RS2517176017 |
IL17RA
|
Health Risk |
Conflicting classifications of pathogenicity |
Immunodeficiency 51, Immunodeficiency 51 |
| RS2517176522 |
USP18
|
Health Risk |
Likely pathogenic |
Pseudo-TORCH syndrome 2, Pseudo-TORCH syndrome 2 |
| RS2517186228 |
RTEL1
|
Health Risk |
Likely pathogenic |
Dyskeratosis congenita, autosomal recessive 5 |
| RS2517193276 |
CFAP298
|
Health Risk |
Likely pathogenic |
— |
| RS2517194487 |
RTEL1
|
Health Risk |
Likely pathogenic |
Pulmonary fibrosis and/or bone marrow failure, Telomere-related |
| RS2517197688 |
RTEL1
|
Health Risk |
Likely pathogenic |
Dyskeratosis congenita, autosomal recessive 5 |
| RS2517201426 |
RTEL1
|
Health Risk |
Likely pathogenic |
Dyskeratosis congenita, autosomal recessive 5 |
| RS2517201429 |
RTEL1
|
Health Risk |
Likely pathogenic |
Dyskeratosis congenita, autosomal recessive 5 |
| RS2517202795 |
RTEL1
|
Health Risk |
Pathogenic |
Dyskeratosis congenita, autosomal recessive 5 |
| RS2517203592 |
RTEL1
|
Health Risk |
Pathogenic |
Telomere syndrome, Telomere syndrome |
| RS2517203807 |
RTEL1
|
Health Risk |
Likely pathogenic |
Dyskeratosis congenita, autosomal recessive 5 |
| RS2517204124 |
LSS
|
Health Risk |
Likely pathogenic |
Inborn genetic diseases, Inborn genetic diseases |
| RS2517219435 |
GNAS
|
Health Risk |
Pathogenic |
— |
| RS2517226100 |
GNAS
|
Health Risk |
Pathogenic |
— |
| RS2517226164 |
GNAS
|
Health Risk |
Conflicting classifications of pathogenicity |
— |
| RS2517227084 |
GNAS
|
Health Risk |
Likely pathogenic |
Pseudohypoparathyroidism type I A, Pseudohypoparathyroidism type I A |
| RS2517241190 |
GNAS
|
Health Risk |
Likely pathogenic |
Pseudohypoparathyroidism type I A, Pseudohypoparathyroidism type I A |
| RS2517248105 |
ITSN1
|
Health Risk |
Likely pathogenic |
— |
| RS2517248411 |
LSS
|
Health Risk |
Pathogenic |
— |
| RS2517248473 |
GNAS
|
Health Risk |
Pathogenic |
— |
| RS2517248665 |
GNAS
|
Health Risk |
Likely pathogenic |
GNAS-related disorder, GNAS-related disorder |
| RS2517250354 |
LSS
|
Health Risk |
Pathogenic |
— |
| RS2517251814 |
SLC25A1
|
Health Risk |
Pathogenic |
— |
| RS2517255245 |
SLC25A1
|
Health Risk |
Pathogenic |
Inborn genetic diseases, Inborn genetic diseases |
| RS2517256882 |
CNOT3
|
Health Risk |
Likely pathogenic |
Intellectual developmental disorder with speech delay, autism |
| RS2517258594 |
GNAS
|
Health Risk |
Pathogenic |
— |
| RS2517258643 |
SLC25A1
|
Health Risk |
Likely pathogenic |
Myasthenic syndrome, congenital |
| RS2517258834 |
SLC25A1
|
Health Risk |
Likely pathogenic |
Myasthenic syndrome, congenital |
| RS2517259277 |
GNAS
|
Health Risk |
Likely pathogenic |
— |
| RS2517260777 |
GNAS
|
Health Risk |
Pathogenic |
— |
| RS2517261214 |
GNAS
|
Health Risk |
Likely pathogenic |
Disorders of GNAS Inactivation, Disorders of GNAS Inactivation |
| RS2517261569 |
SLC25A1
|
Health Risk |
Likely pathogenic |
SLC25A1-related disorder, SLC25A1-related disorder |
| RS2517261629 |
SLC25A1
|
Health Risk |
Pathogenic |
— |
| RS2517263486 |
LSS
|
Health Risk |
Pathogenic |
Alopecia-intellectual disability syndrome 4, Alopecia-intellectual disability syndrome 4 |
| RS2517269281 |
GNAS
|
Health Risk |
Pathogenic |
— |
| RS2517269338 |
GNAS
|
Health Risk |
Likely pathogenic |
Pseudohypoparathyroidism type I A, GNAS-related disorder |
| RS2517272238 |
RUNX1
|
Health Risk |
Pathogenic |
Hereditary thrombocytopenia and hematological cancer predisposition syndrome associated with RUNX1, Hereditary thrombocytopenia and hematologic cancer predisposition syndrome |
| RS2517273773 |
RUNX1
|
Health Risk |
Likely pathogenic |
Hereditary thrombocytopenia and hematologic cancer predisposition syndrome, Hereditary thrombocytopenia and hematological cancer predisposition syndrome associated with RUNX1 |
| RS2517274485 |
RUNX1
|
Health Risk |
Pathogenic |
Hereditary thrombocytopenia and hematological cancer predisposition syndrome associated with RUNX1, Hereditary thrombocytopenia and hematologic cancer predisposition syndrome |
| RS2517274830 |
ADA2
|
Health Risk |
Likely pathogenic |
Deficiency of adenosine deaminase 2, Deficiency of adenosine deaminase 2 |
| RS2517274947 |
ADA2
|
Health Risk |
Likely pathogenic |
Deficiency of adenosine deaminase 2, Deficiency of adenosine deaminase 2 |
| RS2517276433 |
ADA2
|
Health Risk |
Pathogenic |
Deficiency of adenosine deaminase 2, Deficiency of adenosine deaminase 2 |
| RS2517279212 |
ADA2
|
Health Risk |
Likely pathogenic |
— |
| RS2517284734 |
GNAS
|
Health Risk |
Likely pathogenic |
GNAS-related disorder, GNAS-related disorder |
| RS2517294181 |
ADA2
|
Health Risk |
Pathogenic |
Deficiency of adenosine deaminase 2, Deficiency of adenosine deaminase 2 |
| RS2517294264 |
ADA2
|
Health Risk |
Pathogenic |
Deficiency of adenosine deaminase 2, Deficiency of adenosine deaminase 2 |
| RS2517294280 |
CNOT3
|
Health Risk |
Likely pathogenic |
Intellectual developmental disorder with speech delay, autism |
| RS2517294688 |
ADA2
|
Health Risk |
Pathogenic |
Deficiency of adenosine deaminase 2, Deficiency of adenosine deaminase 2 |
| RS2517295940 |
GNAS
|
Health Risk |
Likely pathogenic |
GNAS-related disorder, GNAS-related disorder |
| RS2517296065 |
MCM3AP
|
Health Risk |
Pathogenic |
— |
| RS2517296110 |
GNAS
|
Health Risk |
Pathogenic |
GNAS-related disorder, GNAS-related disorder |
| RS2517296553 |
GNAS
|
Health Risk |
Pathogenic |
Pseudopseudohypoparathyroidism, GNAS-related disorder |
| RS2517297405 |
GNAS
|
Health Risk |
Pathogenic |
— |
| RS2517305221 |
MCM3AP
|
Health Risk |
Pathogenic |
— |
| RS2517308413 |
TSPEAR
|
Health Risk |
Pathogenic |
Tooth agenesis, selective |
| RS2517308868 |
TSPEAR
|
Health Risk |
Pathogenic |
— |
| RS2517308888 |
TSPEAR
|
Health Risk |
Likely pathogenic |
Ectodermal dysplasia 14, hair/tooth type with or without hypohidrosis |
| RS2517320038 |
MCM3AP
|
Health Risk |
Pathogenic |
— |
| RS2517325512 |
MCM3AP
|
Health Risk |
Pathogenic |
— |
| RS2517325803 |
SON
|
Health Risk |
Pathogenic |
ZTTK syndrome, ZTTK syndrome |
| RS2517327023 |
SON
|
Health Risk |
Likely pathogenic |
ZTTK syndrome, ZTTK syndrome |
| RS2517327457 |
SON
|
Health Risk |
Likely pathogenic |
ZTTK syndrome, ZTTK syndrome |
| RS2517328173 |
MCM3AP
|
Health Risk |
Pathogenic |
— |
| RS2517329452 |
RSPH1
|
Health Risk |
Pathogenic |
Primary ciliary dyskinesia, Primary ciliary dyskinesia |
| RS2517329524 |
MCM3AP
|
Health Risk |
Likely pathogenic |
— |
| RS2517333595 |
RSPH1
|
Health Risk |
Pathogenic |
Primary ciliary dyskinesia, Primary ciliary dyskinesia |
| RS2517340869 |
RSPH1
|
Health Risk |
Likely pathogenic |
Primary ciliary dyskinesia, Primary ciliary dyskinesia |
| RS2517344412 |
SON
|
Health Risk |
Likely pathogenic |
ZTTK syndrome, ZTTK syndrome |
| RS2517345434 |
MCM3AP
|
Health Risk |
Likely pathogenic |
MCM3AP-related disorder, MCM3AP-related disorder |
| RS2517345941 |
ADA2
|
Health Risk |
Pathogenic |
Deficiency of adenosine deaminase 2, Deficiency of adenosine deaminase 2 |
| RS2517346791 |
CNOT3
|
Health Risk |
Conflicting classifications of pathogenicity |
Intellectual developmental disorder with speech delay, autism |
| RS2517346966 |
ADA2
|
Health Risk |
Likely pathogenic |
Deficiency of adenosine deaminase 2, Sneddon syndrome |
| RS2517349667 |
SON
|
Health Risk |
Pathogenic |
— |
| RS2517350080 |
SON
|
Health Risk |
Conflicting classifications of pathogenicity |
— |